"Rutherford Regional Health System is a 143-bed acute care facility which offers a broad array of inpatient and outpatient care. Rutherford Regional is dedicated to providing patients with a full range of services to meet your healthcare needs. We provide our services in a caring, professional environment through the teamwork of our medical staff and employees."

During the past decade, Rutherford Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 91 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutherford Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 50 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "National Cancer Institute (NCI)" with 41 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutherford Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NCIC Clinical Trials Group" with 16 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "Eastern Cooperative Oncology Group" with 8 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Rutherford Hospital" are "Breast Cancer" (28 trials), "Lung Cancer" (16 trials), "Lymphoma" (12 trials), "Esophageal Cancer" (9 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Rutherford Hospital" in a lesser frequency.

Most popular intervention types in "Rutherford Hospital" are "Drug" (143 trials), "Other" (65 trials), "Biological" (55 trials), "Radiation" (31 trials) and "Procedure" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "placebo" (21 trials), "radiation therapy" (17 trials), "Bevacizumab" (16 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "Rutherford Hospital" are 121 trials for "All" genders, 38 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Rutherford Hospital". undefined are not yet recruiting, undefined are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 125 completed trials in Rutherford Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Rutherford Hospital, 4 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".